South and Central America Botulinum Toxin Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type (Botulinum toxin A and Botulinum toxin B), Application (Medical and Aesthetic), and End User (Speciality and Dermatology Clinics, Hospitals and Clinics, and Others)
The South & Central America botulinum toxin market is expected to reach US$ 421.9 million by 2028 from US$ 278.7 million in 2021. The market is estimated to rise at a CAGR of 6.1% from 2021 to 2028.
Of late, non-invasive cosmetic treatments have gained substantial popularity among consumers due to minimal downtime, no scarring, low cost, greater accuracy, and fewer complications compared to open procedures. Lower post-treatment downtime is another crucial factor behind the increasing popularity of non-invasive procedures.
Moreover, several manufacturers are working on offering more advanced non-invasive cosmetic treatment products. The rising awareness about non-invasive cosmetic procedures and the increasing availability of user-friendly and technologically advanced non-invasive cosmetic treatment products are boosting the South & Central America botulinum toxin market.
With these new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the botulinum toxin market at an attractive CAGR during the forecast period.
South & Central America Botulinum Toxin Market Revenue and Forecast to 2028 (US$ Million)
Get more information on this report :
South & Central America Botulinum Toxin Market Segmentation
By Product Type
- Type A Botulinum Toxin
- Type B Botulinum Toxin
By Application
- Medical
- Chronic Migraine
- Muscle Spasm
- Over Reactive Bladder
- Hyperhidrosis
- Others
- Aesthetic
- Crow’s Feet
- Forehead Lines
- Frown Lines/ Glabellar
- Square Jaw/ Masseter
- Others
By End-User
- Specialty And Dermatology Clinics
- Hospitals And Clinics
- Others
By Country
- South & Central America
- Brazil
- Argentina
- Rest of South & Central America
Companies Mentioned
- AbbVie Inc.
- Merz Pharma
- Medytox
- Sanofi
- Ipsen Pharma
- Galderma
- Candela Medical
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 South & Central America Botulinum Toxin Market – By Product Type
1.3.2 South & Central America Botulinum Toxin Market – By Application
1.3.3 South & Central America Botulinum Toxin Market – By End User
1.3.4 South & Central America Botulinum Toxin Market – By Geography
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Botulinum Toxin Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 South & Central America PEST Analysis
4.3 Experts Opinion
5. Botulinum Toxin Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Aesthetics Procedures and Use of Botulinum Toxin
5.1.2 Rising Number of Non-invasive Cosmetic Procedures
5.2 Market Restraints
5.2.1 Side-Effects of Botulinum Toxin
5.3 Market Opportunities
5.3.1 Increasing Therapeutic Applications of Botulinum Toxin
5.4 Future Trends
5.4.1 Rise in Product Approvals
5.5 Impact Analysis
6. Botulinum Toxin Market– South & Central America Analysis
6.1 South & Central America Botulinum Toxin Market Revenue Forecast and Analysis
7. South & Central America Botulinum Toxin Market Revenue and Forecasts To 2028– by Product Type
7.1 Overview
7.2 South & Central America Botulinum Toxin Market Revenue Share, by Product Type (2020 and 2028)
7.3 Type A Botulinum Toxin
7.3.1 Overview
7.3.2 Type A Botulinum Toxin: South & Central America Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Type B Botulinum Toxin
7.4.1 Overview
7.4.2 Type B Botulinum Toxin: South & Central America Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
8. South & Central America Botulinum Toxin Market Analysis – By Application
8.1 Overview
8.2 South & Central America Botulinum Toxin Market Revenue Share, by Application (2020 and 2028)
8.3 Medical
8.3.1 Overview
8.3.2 Medical: South & Central America Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
8.3.2.1 Chronic Migraine
8.3.2.1.1 Overview
8.3.2.1.2 Chronic Migraine: South & Central America Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
8.3.2.2 Muscle Spasm
8.3.2.2.1 Overview
8.3.2.2.2 Muscle Spasm: South & Central America Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
8.3.2.3 Over Reactive Bladder
8.3.2.3.1 Overview
8.3.2.3.2 Over Reactive Bladder: South & Central America Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
8.3.2.4 Hyperhidrosis
8.3.2.4.1 Overview
8.3.2.4.2 Hyperhidrosis: South & Central America Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
8.3.2.5 Others
8.3.2.5.1 Overview
8.3.2.5.2 Others: South & Central America Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
8.4 Aesthetic
8.4.1 Overview
8.4.2 Aesthetic: South & Central America Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
8.4.2.1 Crow’s Feet
8.4.2.1.1 Overview
8.4.2.1.2 Crow’s Feet: South & Central America Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
8.4.2.2 Forehead Lines
8.4.2.2.1 Overview
8.4.2.2.2 Forehead Lines: South & Central America Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
8.4.2.3 Frown Lines/ Glabellar
8.4.2.3.1 Overview
8.4.2.3.2 Frown Lines/ Glabellar: South & Central America Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
8.4.2.4 Square Jaw/ Masseter
8.4.2.4.1 Overview
8.4.2.4.2 Square Jaw/ Masseter: South & Central America Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
8.4.2.5 Others
8.4.2.5.1 Overview
8.4.2.5.2 Others: South & Central America Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
9. South & Central America Botulinum Toxin Market Analysis – By End User
9.1 Overview
9.2 South & Central America Botulinum Toxin Market Revenue Share, by End User (2020 and 2028)
9.3 Specialty and Dermatology Clinics
9.3.1 Overview
9.3.2 Specialty and Dermatology Clinics: South & Central America Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
9.4 Hospitals and Clinics
9.4.1 Overview
9.4.2 Hospitals and Clinics: South & Central America Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: South & Central America botulinum toxin market– revenue and forecast to 2028 (us$ million)
10. Botulinum Toxin Market Revenue and Forecasts to 2028 – Geographical Analysis
10.1 South and Central America: Botulinum Toxin Market
10.1.1 Overview
10.1.2 South and Central America: Botulinum Toxin Market - Revenue and Forecasts to 2028 (US$ Million)
10.1.3 South and Central America: Botulinum Toxin Market- Revenue and Forecasts to 2028, By Product Type (US$ Million)
10.1.4 South and Central America: Botulinum Toxin Market, By Application, 2019-2028 (US$ Million)
10.1.4.1 South and Central America: Botulinum Toxin Market, by Medical, 2019–2028 (US$ Million)
10.1.4.2 South and Central America: Botulinum Toxin Market, by Aesthetic, 2019–2028 (US$ Million)
10.1.5 South and Central America: Botulinum Toxin Market, By End User, 2019-2028 (US$ Million)
10.1.6 South and Central America: Botulinum Toxin Market- Revenue and Forecasts to 2028, By Country (%)
10.1.6.1 Brazil: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.1.1 Brazil: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.1.2 Brazil: Botulinum Toxin Market –Revenue and Forecasts to 2028, By Product Type (US$ Million)
10.1.6.1.3 Brazil: Botulinum Toxin Market, By Application, 2019-2028 (US$ Million)
10.1.6.1.3.1 Brazil: Botulinum Toxin Market, by Medical, 2019–2028 (US$ Million)
10.1.6.1.3.2 Brazil: Botulinum Toxin Market, by Aesthetic, 2019–2028 (US$ Million)
10.1.6.1.4 Brazil: Botulinum Toxin Market –Revenue and Forecasts to 2028, By End User (US$ Million)
10.1.6.2 Argentina: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.2.1 Argentina: Botulinum Toxin Market - Revenue and Forecasts to 2028 (US$ Million)
10.1.6.2.2 Argentina: Botulinum Toxin Market Revenue and Forecasts to 2028, By Product Type (US$ Million)
10.1.6.2.3 Argentina: Botulinum Toxin Market, By Application, 2019-2028 (US$ Million)
10.1.6.2.3.1 Argentina: Botulinum Toxin Market, by Medical, 2019–2028 (US$ Million)
10.1.6.2.3.2 Argentina: Botulinum Toxin Market, by Aesthetic, 2019–2028 (US$ Million)
10.1.6.2.4 Argentina: Botulinum Toxin Market Revenue and Forecasts to 2028, By End User (US$ Million)
10.1.6.3 Rest of South and Central America: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.3.1 Rest of South and Central America: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.3.2 Rest of South and Central America: Botulinum Toxin Market, By Product Type, 2019-2028 (US$ Million)
10.1.6.3.3 Rest of South and Central America: Botulinum Toxin Market, By Application, 2019-2028 (US$ Million)
10.1.6.3.3.1 Rest of South and Central America: Botulinum Toxin Market, by Medical, 2019–2028 (US$ Million)
10.1.6.3.3.2 Rest of South and Central America: Botulinum Toxin Market, by Aesthetic, 2019–2028 (US$ Million)
10.1.6.3.4 Rest of South and Central America: Botulinum Toxin Market, By End User, 2019-2028 (US$ Million)
11. Botulinum Toxin Market–Industry Landscape
11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. Company Profiles
12.1 AbbVie Inc.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Merz Pharma
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Medytox
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Sanofi
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Ipsen Pharma
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Galderma
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Candela Medical
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. South and Central America: Botulinum Toxin Market, By Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 2. South and Central America: Botulinum Toxin Market, By Application – Revenue and Forecast to 2028 (US$ Million)
Table 3. South and Central America: Botulinum Toxin Market, By Medical – Revenue and Forecast To 2028 (US$ Million)
Table 4. South and Central America: Botulinum Toxin Market, By Aesthetic – Revenue and Forecast to 2028 (US$ Million)
Table 5. South and Central America: Botulinum Toxin Market, By End User – Revenue and Forecast to 2028 (US$ Million)
Table 6. Brazil: Botulinum Toxin Market, By Product Type -Revenue and Forecast to 2028 (US$ Million)
Table 7. Brazil: Botulinum Toxin Market, By Application – Revenue and Forecast to 2028 (US$ Million)
Table 8. Brazil: Botulinum Toxin Market, By Medical – Revenue and Forecast To 2028 (US$ Million)
Table 9. Brazil: Botulinum Toxin Market, By Aesthetic – Revenue and Forecast to 2028 (US$ Million)
Table 10. Brazil: Botulinum Toxin Market, By End User - Revenue and Forecasts To 2028 (US$ Million)
Table 11. Argentina: Botulinum Toxin Market, By Product Type - Revenue and Forecasts to 2028 (US$ Million)
Table 12. Argentina: Botulinum Toxin Market, By Application – Revenue and Forecast to 2028 (US$ Million)
Table 13. Argentina: Botulinum Toxin Market, By Medical – Revenue and Forecast To 2028 (US$ Million)
Table 14. Argentina: Botulinum Toxin Market, By Aesthetic – Revenue and Forecast to 2028 (US$ Million)
Table 15. Argentina: Botulinum Toxin Market, By End User - Revenue and Forecasts to 2028 (US$ Million)
Table 16. Rest Of South and Central America: Botulinum Toxin Market, By Product Type- Revenue and Forecasts to 2028 (US$ Million)
Table 17. Rest of South and Central America: Botulinum Toxin Market, By Application – Revenue and Forecast to 2028 (US$ Million)
Table 18. Rest of South and Central America: Botulinum Toxin Market, By Medical – Revenue and Forecast To 2028 (US$ Million)
Table 19. Rest of South and Central America: Botulinum Toxin Market, By Aesthetic – Revenue and Forecast to 2028 (US$ Million)
Table 20. Rest Of South and Central America: Botulinum Toxin Market, By End User- Revenue and Forecasts to 2028 (US$ Million)
Table 21. Organic Developments Done by Companies
Table 22. Inorganic Developments Done by Companies
Table 23. Glossary of Terms
LIST OF FIGURES
Figure 1. Botulinum Toxin Market Segmentation
Figure 2. South & Central America Botulinum Toxin Market Overview
Figure 3. Type A Botulinum Toxin Segment Held Largest Share of Product Type Segment in Botulinum Toxin Market
Figure 4. Brazil is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. South & Central America Botulinum Toxin Market, Industry Landscape
Figure 6. South & Central America: PEST Analysis
Figure 7. Experts Opinion
Figure 8. South & Central America Botulinum Toxin Market – By Geography Forecast and Analysis – 2021 - 2028
Figure 9. South & Central America Botulinum Toxin Market Revenue Share, by Product Type (2020 and 2028)
Figure 10. Type A Botulinum Toxin: South & Central America Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. Type B Botulinum Toxin: South & Central America Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. South & Central America Botulinum Toxin Market Revenue Share, by Application (2020 and 2028)
Figure 13. Medical: South & Central America Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
Figure 14. Chronic Migraine: South & Central America Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
Figure 15. Muscle Spasm: South & Central America Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
Figure 16. Over Reactive Bladder: South & Central America Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
Figure 17. Hyperhidrosis: South & Central America Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
Figure 18. Others: South & Central America Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
Figure 19. Aesthetic: South & Central America Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
Figure 20. Crow’s Feet: South & Central America Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
Figure 21. Forehead Lines: South & Central America Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
Figure 22. Frown Lines/ Glabellar: South & Central America Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
Figure 23. Square Jaw/ Masseter: South & Central America Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
Figure 24. Others: South & Central America Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
Figure 25. South & Central America Botulinum Toxin Market Revenue Share, by End User (2020 and 2028)
Figure 26. Specialty and Dermatology Clinics: South & Central America Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
Figure 27. Hospitals and Clinics: South & Central America Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
Figure 28. Others: South & Central America Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
Figure 29. South and Central America: Botulinum Toxin Market, by Key Country – Revenue (2021) (US$ Million)
Figure 30. South and Central America: Botulinum Toxin Market - Revenue and Forecasts to 2028 (US$ Million)
Figure 31. South and Central America: Botulinum Toxin Market -Revenue and Forecasts to 2028, By Country (%)
Figure 32. Brazil: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. Argentina: Botulinum Toxin Market - Revenue and Forecasts to 2028 (US$ Million)
Figure 34. Rest Of South and Central America: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. Growth Strategies Done by the Companies in the Market, (%)
- AbbVie Inc.
- Merz Pharma
- Medytox
- Sanofi
- Ipsen Pharma
- Galderma
- Candela Medical
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America botulinum toxin market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the South & Central America botulinum toxin market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.